Schizophrenia pathways

hsa04080 Neuroactive ligand-receptor interaction - Homo sapiens (human) (34)

hsa:886 CCKAR, CCK-A, CCK1-R, CCKRA; cholecystokinin A receptor; K04194 cholecystokinin A receptor hsa:1133 CHRM5, HM5, MGC41838; cholinergic receptor, muscarinic 5; K04133 muscarinic acetylcholine receptor M5 hsa:1139 CHRNA7, CHRNA7-2, NACHRA7; cholinergic receptor, nicotinic, alpha 7; K04809 nicotinic acetylcholine receptor alpha-7 hsa:1812 DRD1, DADR, DRD1A; dopamine receptor D1; K04144 dopamine receptor D1 hsa:1813 DRD2, D2DR, D2R; dopamine receptor D2; K04145 dopamine receptor D2 hsa:1814 DRD3, D3DR, ETM1, FET1, MGC149204, MGC149205; dopamine receptor D3; K04146 dopamine receptor D3 hsa:1815 DRD4, D4DR; dopamine receptor D4; K04147 dopamine receptor D4 hsa:1816 DRD5, DBDR, DRD1B, DRD1L2, MGC10601; dopamine receptor D5; K05840 dopamine receptor D5 hsa:2550 GABBR1, FLJ92613, GABABR1, GABBR1-3, GB1, GPRC3A, dJ271M21.1.1, dJ271M21.1.2; gamma-aminobutyric acid (GABA) B receptor, 1; K04615 gamma-aminobutyric acid (GABA) B receptor 1 hsa:2554 GABRA1, ECA4, EJM, EJM5; gamma-aminobutyric acid (GABA) A receptor, alpha 1; K05175 gamma-aminobutyric acid (GABA) A receptor alpha-1 hsa:2561 GABRB2, MGC119386, MGC119388, MGC119389; gamma-aminobutyric acid (GABA) A receptor, beta 2; K05182 gamma-aminobutyric acid (GABA) A receptor beta-2 hsa:2568 GABRP, MGC126386, MGC126387; gamma-aminobutyric acid (GABA) A receptor, pi; K05189 gamma-aminobutyric acid (GABA) A receptor pi hsa:2892 GRIA3, GLUR-C, GLUR-K3, GLUR3, GLURC, GluA3, MRX94; glutamate receptor, ionotrophic, AMPA 3; K05199 glutamate receptor, ionotropic, AMPA 3 hsa:2893 GRIA4, GLUR4, GLUR4C, GLURD, GluA4; glutamate receptor, ionotrophic, AMPA 4; K05200 glutamate receptor, ionotropic, AMPA 4 hsa:2894 GRID1, KIAA1220; glutamate receptor, ionotropic, delta 1; K05206 glutamate receptor, ionotropic, delta 1 hsa:2899 GRIK3, EAA5, GLR7, GLUR7, GluR7a; glutamate receptor, ionotropic, kainate 3; K05203 glutamate receptor, ionotropic, kainate 3 hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1 hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D hsa:2913 GRM3, GLUR3, GPRC1C, MGLUR3, mGlu3; glutamate receptor, metabotropic 3; K04605 metabotropic glutamate receptor 2/3 hsa:2914 GRM4, GPRC1D, MGC177594, MGLUR4, mGlu4; glutamate receptor, metabotropic 4; K04607 metabotropic glutamate receptor 4 hsa:2915 GRM5, GPRC1E, MGLUR5, mGlu5; glutamate receptor, metabotropic 5; K04604 metabotropic glutamate receptor 1/5 hsa:2917 GRM7, FLJ40498, GLUR7, GPRC1G, MGLU7, MGLUR7; glutamate receptor, metabotropic 7; K04608 metabotropic glutamate receptor 6/7/8 hsa:3274 HRH2, H2R; histamine receptor H2; K04150 histamine receptor H2 hsa:3350 HTR1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1; 5-hydroxytryptamine (serotonin) receptor 1A; K04153 5-hydroxytryptamine receptor 1 hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2 hsa:3358 HTR2C, 5-HT2C, 5-HTR2C, HTR1C; 5-hydroxytryptamine (serotonin) receptor 2C; K04157 5-hydroxytryptamine receptor 2 hsa:3361 HTR5A, 5-HT5A, MGC138226; 5-hydroxytryptamine (serotonin) receptor 5A; K04161 5-hydroxytryptamine receptor 5 hsa:3362 HTR6, 5-HT6, 5-HT6R; 5-hydroxytryptamine (serotonin) receptor 6; K04162 5-hydroxytryptamine receptor 6 hsa:3363 HTR7, 5-HT7; 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled); K04163 5-hydroxytryptamine receptor 7 hsa:4161 MC5R, MC2; melanocortin 5 receptor; K04203 melanocortin 5 receptor hsa:4988 OPRM1, KIAA0403, LMOR, MOR, MOR1, OPRM; opioid receptor, mu 1; K04215 opioid receptor mu 1 hsa:319100 TAAR6, RP11-295F4.3, TA4, TAR4, TAR6, TRAR4; trace amine associated receptor 6; K05051 trace amine associated receptor hsa:706 TSPO, BPBS, BZRP, DBI, IBP, MBR, PBR, PBS, PKBS, PTBR, mDRC, pk18; translocator protein (18kDa); K05770 benzodiazapine receptor

hsa01100 Metabolic pathways - Homo sapiens (human) (22)

hsa:23305 ACSL6, ACS2, FACL6, FLJ16173, KIAA0837, LACS_6, LACS2, LACS5; acyl-CoA synthetase long-chain family member 6 (EC:6.2.1.3); K01897 long-chain acyl-CoA synthetase [EC:6.2.1.3] hsa:159 ADSS, ADEH, MGC20404; adenylosuccinate synthase (EC:6.3.4.4); K01939 adenylosuccinate synthase [EC:6.3.4.4] hsa:203 AK1; adenylate kinase 1 (EC:2.7.4.3); K00939 adenylate kinase [EC:2.7.4.3] hsa:8854 ALDH1A2, MGC26444, RALDH(II), RALDH2, RALDH2-T; aldehyde dehydrogenase 1 family, member A2 (EC:1.2.1.36); K07249 retinal dehydrogenase [EC:1.2.1.36] hsa:221 ALDH3B1, ALDH4, ALDH7, FLJ26433, FLJ34710; aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5); K00129 aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5] hsa:23600 AMACR, CBAS4, RACE, RM; alpha-methylacyl-CoA racemase (EC:5.1.99.4); K01796 alpha-methylacyl-CoA racemase [EC:5.1.99.4] hsa:4508 ATP6, ATPase6, MTATP6; ATP synthase F0 subunit 6; K02126 F-type H+-transporting ATPase subunit a [EC:3.6.3.14] hsa:1312 COMT; catechol-O-methyltransferase (EC:2.1.1.6); K00545 catechol O-methyltransferase [EC:2.1.1.6] hsa:4519 CYTB, MTCYB; cytochrome b; K00412 ubiquinol-cytochrome c reductase cytochrome b subunit [EC:1.10.2.2] hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3] hsa:1621 DBH, DBM; dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1); K00503 dopamine beta-monooxygenase [EC:1.14.17.1] hsa:2026 ENO2, NSE; enolase 2 (gamma, neuronal) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11] hsa:2730 GCLM, GLCLR; glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2); K11205 glutamate--cysteine ligase regulatory subunit hsa:3613 IMPA2; inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25); K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25] hsa:8564 KMO, dJ317G22.1; kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) (EC:1.14.13.9); K00486 kynurenine 3-monooxygenase [EC:1.14.13.9] hsa:4536 ND2, MTND2; MTND2; K03879 NADH dehydrogenase I subunit 2 [EC:1.6.5.3] hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3] hsa:10400 PEMT, MGC2483, PEAMT, PEMPT, PEMT2, PNMT; phosphatidylethanolamine N-methyltransferase (EC:2.1.1.17); K00551 phosphatidylethanolamine N-methyltransferase [EC:2.1.1.17] hsa:55163 PNPO, FLJ10535, PDXPO; pyridoxamine 5'-phosphate oxidase (EC:1.4.3.5); K00275 pyridoxamine 5'-phosphate oxidase [EC:1.4.3.5] hsa:5625 PRODH, FLJ33744, HSPOX2, MGC148078, MGC148079, PIG6, POX, PRODH1, PRODH2, SCZD4, TP53I6; proline dehydrogenase (oxidase) 1 (EC:1.5.99.8); K00318 proline dehydrogenase [EC:1.5.99.8] hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2] hsa:7166 TPH1, MGC119994, TPRH, TRPH; tryptophan hydroxylase 1 (EC:1.14.16.4); K00502 tryptophan 5-monooxygenase [EC:1.14.16.4]

hsa04020 Calcium signaling pathway - Homo sapiens (human) (18)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:886 CCKAR, CCK-A, CCK1-R, CCKRA; cholecystokinin A receptor; K04194 cholecystokinin A receptor hsa:1133 CHRM5, HM5, MGC41838; cholinergic receptor, muscarinic 5; K04133 muscarinic acetylcholine receptor M5 hsa:1139 CHRNA7, CHRNA7-2, NACHRA7; cholinergic receptor, nicotinic, alpha 7; K04809 nicotinic acetylcholine receptor alpha-7 hsa:1812 DRD1, DADR, DRD1A; dopamine receptor D1; K04144 dopamine receptor D1 hsa:1816 DRD5, DBDR, DRD1B, DRD1L2, MGC10601; dopamine receptor D5; K05840 dopamine receptor D5 hsa:2774 GNAL; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type; K04633 guanine nucleotide binding protein (G protein), alpha polypeptide, olfactory type hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1 hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D hsa:2915 GRM5, GPRC1E, MGLUR5, mGlu5; glutamate receptor, metabotropic 5; K04604 metabotropic glutamate receptor 1/5 hsa:3274 HRH2, H2R; histamine receptor H2; K04150 histamine receptor H2 hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2 hsa:3358 HTR2C, 5-HT2C, 5-HTR2C, HTR1C; 5-hydroxytryptamine (serotonin) receptor 2C; K04157 5-hydroxytryptamine receptor 2 hsa:3361 HTR5A, 5-HT5A, MGC138226; 5-hydroxytryptamine (serotonin) receptor 5A; K04161 5-hydroxytryptamine receptor 5 hsa:3362 HTR6, 5-HT6, 5-HT6R; 5-hydroxytryptamine (serotonin) receptor 6; K04162 5-hydroxytryptamine receptor 6 hsa:3363 HTR7, 5-HT7; 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled); K04163 5-hydroxytryptamine receptor 7 hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa05010 Alzheimer's disease - Homo sapiens (human) (8)

hsa:4508 ATP6, ATPase6, MTATP6; ATP synthase F0 subunit 6; K02126 F-type H+-transporting ATPase subunit a [EC:3.6.3.14] hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:4519 CYTB, MTCYB; cytochrome b; K00412 ubiquinol-cytochrome c reductase cytochrome b subunit [EC:1.10.2.2] hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1 hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3] hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04540 Gap junction - Homo sapiens (human) (6)

hsa:1812 DRD1, DADR, DRD1A; dopamine receptor D1; K04144 dopamine receptor D1 hsa:1813 DRD2, D2DR, D2R; dopamine receptor D2; K04145 dopamine receptor D2 hsa:2915 GRM5, GPRC1E, MGLUR5, mGlu5; glutamate receptor, metabotropic 5; K04604 metabotropic glutamate receptor 1/5 hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2 hsa:3358 HTR2C, 5-HT2C, 5-HTR2C, HTR1C; 5-hydroxytryptamine (serotonin) receptor 2C; K04157 5-hydroxytryptamine receptor 2 hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha

hsa05012 Parkinson's disease - Homo sapiens (human) (6)

hsa:4508 ATP6, ATPase6, MTATP6; ATP synthase F0 subunit 6; K02126 F-type H+-transporting ATPase subunit a [EC:3.6.3.14] hsa:4519 CYTB, MTCYB; cytochrome b; K00412 ubiquinol-cytochrome c reductase cytochrome b subunit [EC:1.10.2.2] hsa:4536 ND2, MTND2; MTND2; K03879 NADH dehydrogenase I subunit 2 [EC:1.6.5.3] hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3] hsa:6571 SLC18A2, MGC120477, MGC120478, MGC26538, SVAT, SVMT, VAT2, VMAT2; solute carrier family 18 (vesicular monoamine), member 2; K08155 MFS transporter, DHA1 family, solute carrier family 18 (vesicular monoamine) hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]

hsa05014 Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) (6)

hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1 hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24] hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16] hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B

hsa04010 MAPK signaling pathway - Homo sapiens (human) (6)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:2259 FGF14, FHF4, MGC119129, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24] hsa:4908 NTF3, HDNF, MGC129711, NGF-2, NGF2, NT3; neurotrophin 3; K04356 neurotrophin 3 hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04720 Long-term potentiation - Homo sapiens (human) (6)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1 hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D hsa:2915 GRM5, GPRC1E, MGLUR5, mGlu5; glutamate receptor, metabotropic 5; K04604 metabotropic glutamate receptor 1/5 hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human) (5)

hsa:1438 CSF2RA, CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, CSF2RX, CSF2RY, GM-CSF-R-alpha, GMCSFR, GMR, MGC3848, MGC4838; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage); K05066 granulocyte-macrophage colony-stimulating factor receptor alpha hsa:1439 CSF2RB, CD131, CDw131, IL3RB, IL5RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B

hsa05016 Huntington's disease - Homo sapiens (human) (5)

hsa:4508 ATP6, ATPase6, MTATP6; ATP synthase F0 subunit 6; K02126 F-type H+-transporting ATPase subunit a [EC:3.6.3.14] hsa:4519 CYTB, MTCYB; cytochrome b; K00412 ubiquinol-cytochrome c reductase cytochrome b subunit [EC:1.10.2.2] hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1 hsa:2915 GRM5, GPRC1E, MGLUR5, mGlu5; glutamate receptor, metabotropic 5; K04604 metabotropic glutamate receptor 1/5 hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3]

hsa05322 Systemic lupus erythematosus - Homo sapiens (human) (5)

hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A hsa:8969 HIST1H2AG, H2A.1b, H2A/p, H2AFP, HIST1H2AI, HIST1H2AK, HIST1H2AL, HIST1H2AM, pH2A/f; histone cluster 1, H2ag; K11251 histone H2A hsa:85235 HIST1H2AH, H2A/S, H2AFALii, MGC171151, dJ86C11.1; histone cluster 1, H2ah; K11251 histone H2A hsa:8970 HIST1H2BJ, H2B/r, H2BFR; histone cluster 1, H2bj; K11252 histone H2B hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa05200 Pathways in cancer - Homo sapiens (human) (4)

hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19, p19Arf; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A hsa:1438 CSF2RA, CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, CSF2RX, CSF2RY, GM-CSF-R-alpha, GMCSFR, GMR, MGC3848, MGC4838; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage); K05066 granulocyte-macrophage colony-stimulating factor receptor alpha hsa:2259 FGF14, FHF4, MGC119129, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor hsa:7976 FZD3, Fz-3, hFz3; frizzled homolog 3 (Drosophila); K02329 frizzled 3

hsa00350 Tyrosine metabolism - Homo sapiens (human) (4)

hsa:221 ALDH3B1, ALDH4, ALDH7, FLJ26433, FLJ34710; aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5); K00129 aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5] hsa:1312 COMT; catechol-O-methyltransferase (EC:2.1.1.6); K00545 catechol O-methyltransferase [EC:2.1.1.6] hsa:1621 DBH, DBM; dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1); K00503 dopamine beta-monooxygenase [EC:1.14.17.1] hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]

hsa00190 Oxidative phosphorylation - Homo sapiens (human) (4)

hsa04360 Axon guidance - Homo sapiens (human) (4)

hsa:22854 NTNG1, KIAA0976, Lmnt1; netrin G1; K07522 netrin G1 hsa:5362 PLXNA2, FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2; plexin A2; K06820 plexin A hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16] hsa:223117 SEMA3D, MGC39708, Sema-Z2, coll-2; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D; K06840 semaphorin 3

hsa00230 Purine metabolism - Homo sapiens (human) (4)

hsa:159 ADSS, ADEH, MGC20404; adenylosuccinate synthase (EC:6.3.4.4); K01939 adenylosuccinate synthase [EC:6.3.4.4] hsa:203 AK1; adenylate kinase 1 (EC:2.7.4.3); K00939 adenylate kinase [EC:2.7.4.3] hsa:5142 PDE4B, DKFZp686F2182, DPDE4, MGC126529, PDE4B5, PDEIVB; phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17] hsa:5144 PDE4D, DKFZp686M11213, DPDE3, FLJ97311, HSPDE4D, PDE4DN2, STRK1; phosphodiesterase 4D, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]

hsa04722 Neurotrophin signaling pathway - Homo sapiens (human) (4)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24] hsa:4908 NTF3, HDNF, MGC129711, NGF-2, NGF2, NT3; neurotrophin 3; K04356 neurotrophin 3 hsa:7531 YWHAE, 14-3-3E, FLJ45465, FLJ53559, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein

hsa04810 Regulation of actin cytoskeleton - Homo sapiens (human) (3)

hsa:1133 CHRM5, HM5, MGC41838; cholinergic receptor, muscarinic 5; K04133 muscarinic acetylcholine receptor M5 hsa:2259 FGF14, FHF4, MGC119129, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor hsa:4627 MYH9, DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA; myosin, heavy chain 9, non-muscle; K10352 myosin heavy chain

hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human) (3)

hsa:9373 PLAA, DOA1, FLJ11281, FLJ12699, PLA2P, PLAP; phospholipase A2-activating protein; K14018 phospholipase A-2-activating protein hsa:81567 TXNDC5, ERP46, EndoPDI, Hcc-2, MGC3178, PDIA15, UNQ364; thioredoxin domain containing 5 (endoplasmic reticulum); K13984 thioredoxin domain-containing protein 5 hsa:7353 UFD1L, UFD1; ubiquitin fusion degradation 1 like (yeast); K14016 ubiquitin fusion degradation protein 1

hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human) (3)

hsa:4099 MAG, GMA, S-MAG, SIGLEC-4A, SIGLEC4A; myelin associated glycoprotein; K06771 myelin associated glycoprotein hsa:9019 MPZL1, FLJ21047, MPZL1b, PZR, PZR1b, PZRa, PZRb; myelin protein zero-like 1; K06770 myelin protein zero hsa:9378 NRXN1, DKFZp313P2036, FLJ35941, Hs.22998, KIAA0578, PTHSL2; neurexin 1; K07377 neurexin

hsa05140 Leishmaniasis - Homo sapiens (human) (3)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa04114 Oocyte meiosis - Homo sapiens (human) (3)

hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16] hsa:7531 YWHAE, 14-3-3E, FLJ45465, FLJ53559, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein

hsa04310 Wnt signaling pathway - Homo sapiens (human) (3)

hsa:27121 DKK4, DKK-4, MGC129562, MGC129563; dickkopf homolog 4 (Xenopus laevis); K02165 dickkopf hsa:7976 FZD3, Fz-3, hFz3; frizzled homolog 3 (Drosophila); K02329 frizzled 3 hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04146 Peroxisome - Homo sapiens (human) (3)

hsa:23305 ACSL6, ACS2, FACL6, FLJ16173, KIAA0837, LACS_6, LACS2, LACS5; acyl-CoA synthetase long-chain family member 6 (EC:6.2.1.3); K01897 long-chain acyl-CoA synthetase [EC:6.2.1.3] hsa:23600 AMACR, CBAS4, RACE, RM; alpha-methylacyl-CoA racemase (EC:5.1.99.4); K01796 alpha-methylacyl-CoA racemase [EC:5.1.99.4] hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3]

hsa04660 T cell receptor signaling pathway - Homo sapiens (human) (3)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24] hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04630 Jak-STAT signaling pathway - Homo sapiens (human) (3)

hsa04110 Cell cycle - Homo sapiens (human) (3)

hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19, p19Arf; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A hsa:7531 YWHAE, 14-3-3E, FLJ45465, FLJ53559, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein

hsa04650 Natural killer cell mediated cytotoxicity - Homo sapiens (human) (3)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma hsa:4277 MICB, PERB11.2; MHC class I polypeptide-related sequence B; K07985 MHC class I-related protein hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04210 Apoptosis - Homo sapiens (human) (3)

hsa:1439 CSF2RB, CD131, CDw131, IL3RB, IL5RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa05142 Chagas disease - Homo sapiens (human) (3)

hsa:2774 GNAL; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type; K04633 guanine nucleotide binding protein (G protein), alpha polypeptide, olfactory type hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa04912 GnRH signaling pathway - Homo sapiens (human) (2)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa05145 Toxoplasmosis - Homo sapiens (human) (2)

hsa00010 Glycolysis / Gluconeogenesis - Homo sapiens (human) (2)

hsa:221 ALDH3B1, ALDH4, ALDH7, FLJ26433, FLJ34710; aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5); K00129 aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5] hsa:2026 ENO2, NSE; enolase 2 (gamma, neuronal) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11]

hsa04640 Hematopoietic cell lineage - Homo sapiens (human) (2)

hsa04940 Type I diabetes mellitus - Homo sapiens (human) (2)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha

hsa04370 VEGF signaling pathway - Homo sapiens (human) (2)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24] hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa05130 Pathogenic Escherichia coli infection - Homo sapiens (human) (2)

hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein

hsa04730 Long-term depression - Homo sapiens (human) (2)

hsa:2892 GRIA3, GLUR-C, GLUR-K3, GLUR3, GLURC, GluA3, MRX94; glutamate receptor, ionotrophic, AMPA 3; K05199 glutamate receptor, ionotropic, AMPA 3 hsa:2915 GRM5, GPRC1E, MGLUR5, mGlu5; glutamate receptor, metabotropic 5; K04604 metabotropic glutamate receptor 1/5

hsa04012 ErbB signaling pathway - Homo sapiens (human) (2)

hsa:3084 NRG1, ARIA, GGF, GGF2, HGL, HRG, HRG1, HRGA, NDF, SMDF; neuregulin 1; K05455 neuregulin 1 hsa:10718 NRG3, HRG3, pro-NRG3; neuregulin 3; K05457 neuregulin 3

hsa00330 Arginine and proline metabolism - Homo sapiens (human) (2)

hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3] hsa:5625 PRODH, FLJ33744, HSPOX2, MGC148078, MGC148079, PIG6, POX, PRODH1, PRODH2, SCZD4, TP53I6; proline dehydrogenase (oxidase) 1 (EC:1.5.99.8); K00318 proline dehydrogenase [EC:1.5.99.8]

hsa05332 Graft-versus-host disease - Homo sapiens (human) (2)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha

hsa03320 PPAR signaling pathway - Homo sapiens (human) (2)

hsa:23305 ACSL6, ACS2, FACL6, FLJ16173, KIAA0837, LACS_6, LACS2, LACS5; acyl-CoA synthetase long-chain family member 6 (EC:6.2.1.3); K01897 long-chain acyl-CoA synthetase [EC:6.2.1.3] hsa:2173 FABP7, B-FABP, BLBP, DKFZp547J2313, FABPB, MRG; fatty acid binding protein 7, brain; K08756 fatty acid-binding protein 7, brain

hsa00260 Glycine, serine and threonine metabolism - Homo sapiens (human) (2)

hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3] hsa:63826 SRR, ILV1, ISO1; serine racemase (EC:5.1.1.18); K12235 serine racemase [EC:5.1.1.18]

hsa04260 Cardiac muscle contraction - Homo sapiens (human) (2)

hsa04330 Notch signaling pathway - Homo sapiens (human) (2)

hsa:4855 NOTCH4, FLJ16302, INT3, MGC74442, NOTCH3; notch 4; K02599 Notch hsa:9253 NUMBL, CAG3A, CTG3a, NBL, NUMB-R, NUMBLIKE, NUMBR, TNRC23; numb homolog (Drosophila)-like; K06057 numb

hsa05218 Melanoma - Homo sapiens (human) (2)

hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19, p19Arf; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A hsa:2259 FGF14, FHF4, MGC119129, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor

hsa04920 Adipocytokine signaling pathway - Homo sapiens (human) (2)

hsa:23305 ACSL6, ACS2, FACL6, FLJ16173, KIAA0837, LACS_6, LACS2, LACS5; acyl-CoA synthetase long-chain family member 6 (EC:6.2.1.3); K01897 long-chain acyl-CoA synthetase [EC:6.2.1.3] hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B

hsa05146 Amoebiasis - Homo sapiens (human) (2)

hsa00380 Tryptophan metabolism - Homo sapiens (human) (2)

hsa:8564 KMO, dJ317G22.1; kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) (EC:1.14.13.9); K00486 kynurenine 3-monooxygenase [EC:1.14.13.9] hsa:7166 TPH1, MGC119994, TPRH, TRPH; tryptophan hydroxylase 1 (EC:1.14.16.4); K00502 tryptophan 5-monooxygenase [EC:1.14.16.4]

hsa04115 p53 signaling pathway - Homo sapiens (human) (2)

hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19, p19Arf; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A hsa:51246 SHISA5, SCOTIN, hShisa5; shisa homolog 5 (Xenopus laevis); K10135 scotin

hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa05219 Bladder cancer - Homo sapiens (human) (1)

hsa00750 Vitamin B6 metabolism - Homo sapiens (human) (1)

hsa:55163 PNPO, FLJ10535, PDXPO; pyridoxamine 5'-phosphate oxidase (EC:1.4.3.5); K00275 pyridoxamine 5'-phosphate oxidase [EC:1.4.3.5]

hsa00071 Fatty acid metabolism - Homo sapiens (human) (1)

hsa:23305 ACSL6, ACS2, FACL6, FLJ16173, KIAA0837, LACS_6, LACS2, LACS5; acyl-CoA synthetase long-chain family member 6 (EC:6.2.1.3); K01897 long-chain acyl-CoA synthetase [EC:6.2.1.3]

hsa05330 Allograft rejection - Homo sapiens (human) (1)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa04530 Tight junction - Homo sapiens (human) (1)

hsa:4627 MYH9, DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA; myosin, heavy chain 9, non-muscle; K10352 myosin heavy chain

hsa05214 Glioma - Homo sapiens (human) (1)

hsa04914 Progesterone-mediated oocyte maturation - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa04130 SNARE interactions in vesicular transport - Homo sapiens (human) (1)

hsa:9342 SNAP29, CEDNIK, FLJ21051, SNAP-29; synaptosomal-associated protein, 29kDa; K08509 synaptosomal-associated protein, 29kDa

hsa00340 Histidine metabolism - Homo sapiens (human) (1)

hsa:221 ALDH3B1, ALDH4, ALDH7, FLJ26433, FLJ34710; aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5); K00129 aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5]

hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human) (1)

hsa:3613 IMPA2; inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25); K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25]

hsa00360 Phenylalanine metabolism - Homo sapiens (human) (1)

hsa:221 ALDH3B1, ALDH4, ALDH7, FLJ26433, FLJ34710; aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5); K00129 aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5]

hsa04662 B cell receptor signaling pathway - Homo sapiens (human) (1)

hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04140 Regulation of autophagy - Homo sapiens (human) (1)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa00480 Glutathione metabolism - Homo sapiens (human) (1)

hsa:2730 GCLM, GLCLR; glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2); K11205 glutamate--cysteine ligase regulatory subunit

hsa05223 Non-small cell lung cancer - Homo sapiens (human) (1)

hsa04740 Olfactory transduction - Homo sapiens (human) (1)

hsa05144 Malaria - Homo sapiens (human) (1)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa03018 RNA degradation - Homo sapiens (human) (1)

hsa:2026 ENO2, NSE; enolase 2 (gamma, neuronal) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11]

hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) (1)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C

hsa04510 Focal adhesion - Homo sapiens (human) (1)

hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]

hsa00982 Drug metabolism - cytochrome P450 - Homo sapiens (human) (1)

hsa:221 ALDH3B1, ALDH4, ALDH7, FLJ26433, FLJ34710; aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5); K00129 aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5]

hsa04742 Taste transduction - Homo sapiens (human) (1)

hsa:2914 GRM4, GPRC1D, MGC177594, MGLUR4, mGlu4; glutamate receptor, metabotropic 4; K04607 metabotropic glutamate receptor 4

hsa00562 Inositol phosphate metabolism - Homo sapiens (human) (1)

hsa:3613 IMPA2; inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25); K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25]

hsa04972 Pancreatic secretion - Homo sapiens (human) (1)

hsa:886 CCKAR, CCK-A, CCK1-R, CCKRA; cholecystokinin A receptor; K04194 cholecystokinin A receptor

hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa05410 Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) (1)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C

hsa05020 Prion diseases - Homo sapiens (human) (1)

hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha

hsa04622 RIG-I-like receptor signaling pathway - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa04350 TGF-beta signaling pathway - Homo sapiens (human) (1)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa05414 Dilated cardiomyopathy - Homo sapiens (human) (1)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C

hsa05416 Viral myocarditis - Homo sapiens (human) (1)

hsa:4627 MYH9, DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA; myosin, heavy chain 9, non-muscle; K10352 myosin heavy chain

hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa00472 D-Arginine and D-ornithine metabolism - Homo sapiens (human) (1)

hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3]

hsa04512 ECM-receptor interaction - Homo sapiens (human) (1)

hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]

hsa04971 Gastric acid secretion - Homo sapiens (human) (1)

hsa:3274 HRH2, H2R; histamine receptor H2; K04150 histamine receptor H2

hsa03050 Proteasome - Homo sapiens (human) (1)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa05217 Basal cell carcinoma - Homo sapiens (human) (1)

hsa:7976 FZD3, Fz-3, hFz3; frizzled homolog 3 (Drosophila); K02329 frizzled 3

hsa00140 Steroid hormone biosynthesis - Homo sapiens (human) (1)

hsa:1312 COMT; catechol-O-methyltransferase (EC:2.1.1.6); K00545 catechol O-methyltransferase [EC:2.1.1.6]

hsa04930 Type II diabetes mellitus - Homo sapiens (human) (1)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C

hsa04145 Phagosome - Homo sapiens (human) (1)

hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha

hsa05220 Chronic myeloid leukemia - Homo sapiens (human) (1)

hsa00120 Primary bile acid biosynthesis - Homo sapiens (human) (1)

hsa:23600 AMACR, CBAS4, RACE, RM; alpha-methylacyl-CoA racemase (EC:5.1.99.4); K01796 alpha-methylacyl-CoA racemase [EC:5.1.99.4]

hsa05131 Shigellosis - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa00564 Glycerophospholipid metabolism - Homo sapiens (human) (1)

hsa:10400 PEMT, MGC2483, PEAMT, PEMPT, PEMT2, PNMT; phosphatidylethanolamine N-methyltransferase (EC:2.1.1.17); K00551 phosphatidylethanolamine N-methyltransferase [EC:2.1.1.17]

hsa04270 Vascular smooth muscle contraction - Homo sapiens (human) (1)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C

hsa04612 Antigen processing and presentation - Homo sapiens (human) (1)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa04320 Dorso-ventral axis formation - Homo sapiens (human) (1)

hsa:4855 NOTCH4, FLJ16302, INT3, MGC74442, NOTCH3; notch 4; K02599 Notch

hsa05212 Pancreatic cancer - Homo sapiens (human) (1)

hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) (1)

hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]

hsa00250 Alanine, aspartate and glutamate metabolism - Homo sapiens (human) (1)

hsa:159 ADSS, ADEH, MGC20404; adenylosuccinate synthase (EC:6.3.4.4); K01939 adenylosuccinate synthase [EC:6.3.4.4]

hsa00830 Retinol metabolism - Homo sapiens (human) (1)

hsa:8854 ALDH1A2, MGC26444, RALDH(II), RALDH2, RALDH2-T; aldehyde dehydrogenase 1 family, member A2 (EC:1.2.1.36); K07249 retinal dehydrogenase [EC:1.2.1.36]

hsa04916 Melanogenesis - Homo sapiens (human) (1)

hsa:7976 FZD3, Fz-3, hFz3; frizzled homolog 3 (Drosophila); K02329 frizzled 3

hsa00980 Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human) (1)

hsa:221 ALDH3B1, ALDH4, ALDH7, FLJ26433, FLJ34710; aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5); K00129 aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5]

These maps, etched out by numerous Schizophrenia susceptibility gene candidates are generated by Kegg pathways from the Kanehisa laboratories with thanks and are subject to their copyright conditions: Genes are enhanced by

Pathway Search Result